ArticleMolecular cancer therapeutics2018

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.

Michael D Oberst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.